Sunday, February 21, 2016

Comparison of Quality of Life and Sexuality between Cervical Cancer Survivors and Healthy Women

PURPOSE:
The purpose of this study is to compare quality of life (QoL) and sexual functioning between sexually active cervical cancer survivors and healthy women.

MATERIALS AND METHODS:
In this cross-sectional study, propensity-score-matched cervical cancer survivors (n=104) and healthy women (n=104) were compared. All women had engaged in sexual activity within the previous 3 months, and cervical cancer survivors showed no evidence of disease after primary treatment. QoL and sexual functioning were assessed using three questionnaires; the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30), Cervical Cancer Module (EORTC QLQ-CX24), and the Female Sexual Function Index (FSFI).

RESULTS:
Significantly higher scores for lymphedema were observed in the cervical cancer survivors group compared with the healthy women group (mean, 20.2 vs. 12.2; P < 0.05). Sexuality, both in terms of sexual activity, sexual enjoyment, and sexual worry (EORTC QLQ-CX24), and in terms of desire, arousal, lubrication, orgasm, satisfaction, and pain (FSFI) were similar between the groups. When the scale of sexual/vaginal functioning in EORTC QLQ-CX24 was divided into individual questions, cervical cancer survivors reported shorter vaginal length than the control group, but without statistical significance (mean, 80.6 vs. 85.4; P = 0.077).

CONCLUSION:
Compared with healthy women, sexuality was not impaired in cervical cancer survivors who showed no evidence of disease after primary treatment and engaging in sexual activity. Further prospective cohort studies are warranted.

Full PDF article at:   http://goo.gl/Nsx13y

By:  Lee Y1Lim MC1,2,3Kim SI4Joo J3,5Lee DO1Park SY1,2.
  • 1Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
  • 2Gynecologic Cancer Branch, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
  • 3Department of Cancer Control, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea.
  • 4Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea.
  • 5Biometric Research Branch, Research Institute and Hospital, National Cancer Center, Goyang, Korea. 
  •  2016 Feb 12. doi: 10.4143/crt.2015.425.



No comments:

Post a Comment